Skip to main content

Advertisement

SpringerLink
Log in

Safety and Efficacy of Bariatric and Metabolic Surgery

  • The Obesity Epidemic: Causes and Consequences (A Cameron and K Backholer, Section Editors)
  • Published:
Current Obesity Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Bariatric surgery is the most effective and durable method for treating obesity. This review highlights the results and safety of bariatric surgery.

Recent Findings

The global prevalence of obesity and its related comorbidities including cancer are on the rise. Bariatric surgery has demonstrated more robust and durable weight loss than current medical treatment. Bariatric surgery also reduces significantly the risk of complications associated with obesity comorbidities, such as diabetes and cardiovascular disease, and the risk of mortality in comparison with medical management. Due to accreditation efforts, the safety profile of bariatric surgery is equivalent or superior to many common operations.

Summary

Obesity is associated with increased all cause morbidity and mortality. The current bariatric procedures produce significant and durable weight loss and reduce the morbidity and mortality associated with obesity-related diseases substantially. The risk/benefit ratio for bariatric surgery is decidedly in favor for the benefit for bariatric surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (Accessed on 10/20/2019).

  2. https://www.cdc.gov/obesity/data/adult.html (Accessed on 10/20/2019).

  3. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:1492. https://doi.org/10.1056/NEJMc1701944.

    Article  PubMed  Google Scholar 

  4. van Kruijsdijk RCM, van der Wall E, Visseren FLJ. Obesity and Cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomark Prev. 2009;18(10):2569–78. https://doi.org/10.1158/1055-9965.EPI-09-0372.

    Article  CAS  Google Scholar 

  5. Sung H, Siegel RL, Rosenberg PS. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019;4(3):e137–47. https://doi.org/10.1016/S2468-2667(18)30267-6.

    Article  PubMed  Google Scholar 

  6. Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA Surg. 2018;153:427–34. https://doi.org/10.1001/jamasurg.2017.5025.

    Article  PubMed  Google Scholar 

  7. Puzziferri N, Roshek TB, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42. https://doi.org/10.1001/jama.2014.10706.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;(8). https://doi.org/10.1002/14651858.CD003641.pub4.

  9. Jakobsen GS, Småstuen MC, Sandbu R, Nordstrand N, Hofsø D, Lindberg M, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA. 2018;319:291–301. https://doi.org/10.1001/jama.2017.21055.

    Article  PubMed  PubMed Central  Google Scholar 

  10. • Aminian A, Brethauer SA, Kirwan JP, Kashyap SR, Burguera B, Schauer PR. How safe is metabolic/diabetes surgery? Diabetes Obes Metab. 2015;17:198–201. https://doi.org/10.1111/dom.12405Bariatric surgery is safe and complications rates are comparable to such common operations as cholecystectomy and appendectomy.

    Article  PubMed  CAS  Google Scholar 

  11. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers (Accessed on 4/2/2020).

  12. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO worldwide survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94. https://doi.org/10.1007/s11695-018-3450-2.

    Article  PubMed  Google Scholar 

  13. Sjöström L. Review of the key results from the Swedish obese subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273:219–34. https://doi.org/10.1111/joim.12012.

    Article  PubMed  Google Scholar 

  14. Schauer PR, Kashyap SR, Wolski K, Berthauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567. https://doi.org/10.1056/NEJMoa1200225.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  15. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Berthauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes – 3-year outcomes. N Engl J Med. 2014;370:2002–13. https://doi.org/10.1056/NEJMoa1401329.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. • Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Berthauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcome. N Engl J Med. 2017;376:641–51. https://doi.org/10.1056/NEJMoa1600869The 5 year results from a nonblinded randomized controlled trial has shown that bariatric surgery with intensive medical therapy is more effective than intensive medical therapy alone in decreasing or resolving hyperglycemia in those with T2DM and BMI 27–43 kg/m2.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Sudan R, Maciejewski ML, Wilk AR, Nguyen NT, Ponce J, Morton JM. Comparative effectiveness of primary bariatric operations in the United States. Surg Obes Relat Dis. 2017;13:826–35. https://doi.org/10.1016/j.soard.2017.01.021.

    Article  PubMed  Google Scholar 

  18. Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Murali S, et al. Comparative effectiveness and safety of bariatric procedures for weight loss: a PCORnet cohort study. Ann Intern Med. 2018;169:741–50. https://doi.org/10.7326/M17-2786.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Golzarand M, Toolabi K, Farid R. The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults. Surg Endosc. 2017;31:4331–45. https://doi.org/10.1007/s00464-017-5505-1.

    Article  PubMed  Google Scholar 

  20. O’Brien PE, Hindle A, Brennan L, Skinner S, Burton P, Smith A, et al. Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-Centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29:3–14. https://doi.org/10.1007/s11695-018-3525-0.

    Article  PubMed  Google Scholar 

  21. Peterli R, Wölnerhanssen BK, Peters T, Vetter D, Kröll D, Borbély Y, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319:255–65. https://doi.org/10.1001/jama.2017.20897.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Salminen P, Helmiö M, Ovaska J, Juuti A, Leivonen M, Peromaa-Haavisto P, et al. Effect of laparoscopic sleeve Gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319:241–54. https://doi.org/10.1001/jama.2017.20313.

    Article  PubMed  PubMed Central  Google Scholar 

  23. •• Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77. https://doi.org/10.2337/dc16-0236An international consensus conference of clinicians and scholars (75% non-surgeons) held in 2015, issued a Joint Statement endorsed by 45 international organizations that for the first time incorporates metabolic surgery in the treatment algorithm for T2DM.

    Article  PubMed  CAS  Google Scholar 

  24. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85. https://doi.org/10.1056/NEJMoa1200111.

    Article  PubMed  CAS  Google Scholar 

  25. Carlsson LMS, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695–704. https://doi.org/10.1056/NEJMoa1112082.

    Article  CAS  PubMed  Google Scholar 

  26. Sjöström L, Peltonen M, Jacobson P, Sjöström CD, Karason K, Wedel H, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65. https://doi.org/10.1001/jama.2011.1914.

    Article  PubMed  Google Scholar 

  27. Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132–42. https://doi.org/10.1161/CIRCULATIONAHA.117.032130.

    Article  PubMed  Google Scholar 

  28. Schiavon CA, Ikeoka D, Santucci EV, Santos RN, Damiani LP, Bueno PT, et al. Effects of bariatric surgery versus medical therapy on the 24-hour ambulatory blood pressure and the prevalence of resistant hypertension. Hypertension. 2019;73:571–7. https://doi.org/10.1161/HYPERTENSIONAHA.118.12290.

    Article  PubMed  CAS  Google Scholar 

  29. •• Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019;322(13):1271–82. https://doi.org/10.1001/jama.2019.14231A large retrospective cohort study of patients with type 2 diabetes and obesity, including 2287 with metabolic surgery and 11,435 matched controls, metabolic surgery was associated with a significantly lower risk of major adverse cardiovascular events at 8 years (all-cause mortality, coronary artery events, cerebrovascular events, heart failure, nephropathy, and atrial fibrillation). Surgery was also associated with significantly lower overall mortality rate.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Raygor V, Garcia L, Morton JM. The comparative effect of Roux-en-Y gastric bypass and sleeve gastrectomy on 10-year and lifetime atherosclerotic cardiovascular disease risk. Obes Surg. 2019;29(10):3111–7. https://doi.org/10.1007/s11695-019-03948-8.

    Article  PubMed  Google Scholar 

  31. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society. Circulation. 2014;129(suppl 2):S102–38. https://doi.org/10.1161/01.cir.0000437739.71477.ee.

    Article  PubMed  Google Scholar 

  32. https://www.facs.org/quality-programs/mbsaqip (Accessed on 10/20/2019).

  33. Morton JM, Garg T, Nguyen N. Does hospital accreditation impact bariatric surgery safety? Ann Surg. 2014;260(3):504–9. https://doi.org/10.1097/SLA.0000000000000891.

    Article  PubMed  Google Scholar 

  34. Daigle CR, Brethauer SA, Tu C, Petrick AT, Morton JM, Schauer PR, et al. Which postoperative complications matter most after bariatric surgery? Prioritizing quality improvement efforts to improve national outcomes. Surg Obes Relat Dis. 2018;14:652–7. https://doi.org/10.1016/j.soard.2018.01.008.

    Article  PubMed  Google Scholar 

  35. Kim JH, Wolfe B. Bariatric/metabolic surgery: short- and long-term safety. Curr Atheroscler Rep. 2012;14:597–605. https://doi.org/10.1007/s11883-012-0287-3.

    Article  PubMed  Google Scholar 

  36. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54. https://doi.org/10.1056/NEJMoa0901836.

    Article  PubMed  Google Scholar 

  37. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149:275–87. https://doi.org/10.1001/jamasurg.2013.3654.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Mazer LM, Azagury DE, Morton JM. Quality of life after bariatric surgery. Curr Obes Rep. 2017;6:204–10. https://doi.org/10.1007/s13679-017-0266-7.

    Article  PubMed  Google Scholar 

  39. Julia C, Ciangura C, Capuron L, Bouillot JL, Basdevant A, Poitou C, et al. Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities. Diabetes Metab. 2013;39(2):148–54. https://doi.org/10.1016/j.diabet.2012.10.008.

    Article  PubMed  CAS  Google Scholar 

  40. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamon WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61. https://doi.org/10.1056/NEJMoa066603.

    Article  PubMed  CAS  Google Scholar 

  41. Reges O, Greenland P, Dicker D, Leibowitz M, Hoshen M, Gofer I, et al. Association of bariatric surgery ssing laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve Gastrectomy vs usual care obesity management with all-cause mortality. JAMA. 2018;319:279–90. https://doi.org/10.1001/jama.2017.20513.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Stanford FC, Alfaris N, Gomez G, Ricks ET, Shukla AP, Corey KE, et al. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study. Surg Obes Relat Dis. 2017;13:491–501. https://doi.org/10.1016/j.soard.2016.10.018.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Bariatric and Gastrointestinal Surgery, Yale School of Medicine, P.O. Box 208062, New Haven, CT, 06520, USA

    Saber Ghiassi & John M. Morton

Authors
  1. Saber Ghiassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John M. Morton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Saber Ghiassi.

Ethics declarations

Conflict of Interest

The authors declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on The Obesity Epidemic: Causes and Consequences

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghiassi, S., Morton, J.M. Safety and Efficacy of Bariatric and Metabolic Surgery. Curr Obes Rep 9, 159–164 (2020). https://doi.org/10.1007/s13679-020-00377-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13679-020-00377-y

Keywords

Search

Navigation